Cargando…
Identification of a Splice Variant (c.5074+3A>C) of BRCA1 by RNA Sequencing and TOPO Cloning
Grading the pathogenicity of BRCA1/2 variants has great clinical importance in patient treatment as well as in the prevention and screening of hereditary breast and ovarian cancer (HBOC). For accurate evaluation, confirming the splicing effect of a possible splice site variant is crucial. We report...
Autores principales: | Hong, Jinyoung, Kim, Ji Hyun, Ahn, Se Hee, Gu, Hyunjung, Chang, Suhwan, Lee, Woochang, Kim, Dae-Yeon, Chun, Sail, Min, Won-Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229931/ https://www.ncbi.nlm.nih.gov/pubmed/34073420 http://dx.doi.org/10.3390/genes12060810 |
Ejemplares similares
-
RNA Sequencing for Elucidating an Intronic Variant of Uncertain Significance (SDHD c.314+3A>T) in Splicing Site Consensus Sequences
por: Gu, Hyunjung, et al.
Publicado: (2022) -
RNA Sequencing Provides Evidence for Pathogenicity of a Novel CHEK2 Splice Variant (C.1009-7T>G)
por: Na, Rae, et al.
Publicado: (2022) -
Identification of a Novel Splice Variant (c.423-8A>G) of APC by RNA Sequencing
por: Kim, Aram, et al.
Publicado: (2020) -
Performance evaluation of an amplicon‐based next‐generation sequencing panel for BRCA1 and BRCA2 variant detection
por: Park, Kuenyoul, et al.
Publicado: (2020) -
Intuitive Modification of the Friedewald Formula for Calculation of LDL-Cholesterol
por: Hong, Jinyoung, et al.
Publicado: (2023)